Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Journal of Virology|December 13, 2019
Impact of T<sub>h</sub>1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus MacaquesAnil Verma, Brian A Schmidt, Sonny R Elizaldi, et al.
JCI Insight|March 11, 2020
Antibody response patterns in chikungunya febrile phase predict protection versus progression to chronic arthritisKaustuv Nayak, Vineet Jain, Manpreet Kaur, et al.
Cell Reports|October 27, 2021
Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammationAnil Verma, Chase E Hawes, Yashavanth Shaan Lakshmanappa, et al.
Hepatology (Baltimore, Md.)|August 10, 2020
Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected CellsJoannah R Fergusson, Zoë Wallace, Mary M Connolly, et al.
Plos Pathogens|July 6, 2021
Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaquesKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Pageof 10